These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 872467)

  • 1. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
    Hancock BW; Bruce L; Ward AM; Richmond J
    Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
    Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
    Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
    Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
    G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
    Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic damage due to chemotherapy and radiotherapy in children with lymphoma].
    Vuković I; Janković M; Simonović J; Konjević G
    Srp Arh Celok Lek; 1984 Mar; 112(3):287-94. PubMed ID: 6495052
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
    Advani SH; Gangal SG; Gopal R; Nair CN; Dinshaw KA; Desai PB
    Indian J Med Res; 1985 Mar; 81():306-12. PubMed ID: 4018861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma].
    Danieli G; Malini PL; Montro NI M; Cremonini G; Lauria F; Tura S
    G Clin Med; 1972 Jun; 53(6):277-89. PubMed ID: 4655306
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Longtime complications in patients with malignant lymphomas following chemo- and (or) radiotherapy. Virus infections--leukemias--sterility].
    Delbrück H; Teillet F; Andrieu JM; Schmitt G; Bayle O; Wetter O
    Dtsch Med Wochenschr; 1978 May; 103(18):789-93. PubMed ID: 348434
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of splenectomy, radiotherapy and chemotherapy on the immune response in Hodgkin's disease.
    Van Rijswijk RE; Sybesma JP; Kuipers JT; Zegers BJ; Borst-Eilers E
    Neth J Med; 1976; 19(4-5):201-8. PubMed ID: 980188
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
    Sutherland RM; McCredie JA; Inch WR
    Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
    [No Abstract]   [Full Text] [Related]  

  • 15. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological aspects of malignant lymphomas].
    Hancock BW; Richmond J
    Recenti Prog Med; 1978 Feb; 64(2):217-29. PubMed ID: 347546
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular immune responses and prognosis in malignant lymphomas.
    Sokal JE; Aungst CW
    Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
    [No Abstract]   [Full Text] [Related]  

  • 18. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Humoral and cellular immunologic defense reactions in lymphogranulomatosis].
    Patakfalvi A; Gógl A; Balázs M; Simon K; Kovács Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):59-67. PubMed ID: 4110784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.